Tag #Mash

Showing 1 to 5 of 5 results

theguardian.com

🌐 85% Global Worthiness

Jun 5, 16:15

15 Million Undiagnosed Cases of Aggressive Fatty Liver Disease in US and Europe

Research reveals that over 15 million people in the US, UK, Germany, and France are undiagnosed with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, resulting in significant economic and health consequences; improved screening, treatment, and...

15 Million Undiagnosed Cases of Aggressive Fatty Liver Disease in US and Europe

Research reveals that over 15 million people in the US, UK, Germany, and France are undiagnosed with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, resulting in significant economic and health consequences; improved screening, treatment, and...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the economic and health consequences of the significant underdiagnosis of MASH, and what actions are proposed to mitigate these effects?

The study reveals a significant underdiagnosis of MASH across the US and Europe, with diagnosis rates below 18% despite a prevalence of nearly 3-4% in the studied populations. This underdiagnosis has substantial economic consequences, with predicted healthcare costs tripling in the next 20 years if diagnosis rates don't improve. The lack of awareness translates to billions of pounds in lost productivity and compromised health.

theguardian.com

🌐 75% Global Worthiness

May 31, 16:09

Loretta Swit, *M*A*S*H* Actress, Dies at 87

Loretta Swit, the American actress best known for playing Margaret "Hot Lips" Houlihan in the TV series *M*A*S*H*, died aged 87; she also starred in the 1981 pilot of *Cagney & Lacey* before being replaced and had a significant stage career, including roles in *Shirley Valentine* and *The Vagina Mon...

Loretta Swit, *M*A*S*H* Actress, Dies at 87

Loretta Swit, the American actress best known for playing Margaret "Hot Lips" Houlihan in the TV series *M*A*S*H*, died aged 87; she also starred in the 1981 pilot of *Cagney & Lacey* before being replaced and had a significant stage career, including roles in *Shirley Valentine* and *The Vagina Mon...

Progress

32% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

How did Loretta Swit's personal advocacy influence the portrayal of her character in *M*A*S*H*?

Swit's impact extends beyond *M*A*S*H*. Her involvement in the pilot for *Cagney & Lacey*, a groundbreaking police drama featuring two female leads, highlights her commitment to portraying strong women. However, contractual obligations prevented her from securing the role permanently.

es.euronews.com

🌐 85% Global Worthiness

May 1, 19:18

Semaglutide Shows Promise in Treating Metabolic-Associated Fatty Liver Disease

A new study published in the New England Journal of Medicine reveals that semaglutide, a key ingredient in popular weight-loss drugs, significantly improved liver inflammation and scarring in patients with metabolic-associated fatty liver disease (MASH) after 72 weeks, with 33% of patients on semagl...

Semaglutide Shows Promise in Treating Metabolic-Associated Fatty Liver Disease

A new study published in the New England Journal of Medicine reveals that semaglutide, a key ingredient in popular weight-loss drugs, significantly improved liver inflammation and scarring in patients with metabolic-associated fatty liver disease (MASH) after 72 weeks, with 33% of patients on semagl...

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What role did lifestyle interventions play in the study's outcomes, and how does this affect the interpretation of semaglutide's impact?

The positive results from this advanced-stage clinical trial, funded by Novo Nordisk, suggest semaglutide could be a viable treatment for MASH, a condition linked to obesity, type 2 diabetes, and hypertension. While lifestyle changes also played a role (34% of the placebo group saw reduced inflammation), semaglutide's impact on both inflammation and scarring was substantially greater. This highlights the potential for a dual approach combining medication with lifestyle interventions.

edition.cnn.com

🌐 75% Global Worthiness

May 31, 01:10

M*A*S*H" Actress Loretta Swit Dies at 87

Loretta Swit, the two-time Emmy Award-winning actress who played Major Margaret "Hot Lips" Houlihan on the iconic TV series "M*A*S*H," died Friday at 87 in her New York City home; her portrayal of Houlihan evolved from a stereotypical character to a complex and relatable figure over the 11-year run ...

M*A*S*H" Actress Loretta Swit Dies at 87

Loretta Swit, the two-time Emmy Award-winning actress who played Major Margaret "Hot Lips" Houlihan on the iconic TV series "M*A*S*H," died Friday at 87 in her New York City home; her portrayal of Houlihan evolved from a stereotypical character to a complex and relatable figure over the 11-year run ...

Progress

20% Bias Score

ShareSaveArticle

Gender Equality

12345678

Previous 1 of 8 Next

How did Loretta Swit's personal involvement shape the development of her character, Margaret Houlihan, throughout the series' run?

Swit's contribution to "M*A*S*H" extended beyond acting; she actively shaped Houlihan's character arc, advocating for more depth and realism. Her influence on the show's scriptwriters is evident in Houlihan's progression from a one-dimensional character to a multifaceted individual. This reflects the growing feminist movement of the 1970s and Swit's personal commitment to portraying women authentically.

abcnews.go.com

🌐 85% Global Worthiness

May 1, 04:13

Wegovy Ingredient Shows Promise in Treating Fatty Liver Disease

Research published in the New England Journal of Medicine shows that semaglutide, the active ingredient in Wegovy, significantly reduced liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease affecting an estimated 1.5% to 6.5%...

Wegovy Ingredient Shows Promise in Treating Fatty Liver Disease

Research published in the New England Journal of Medicine shows that semaglutide, the active ingredient in Wegovy, significantly reduced liver inflammation and scarring in patients with metabolic dysfunction-associated steatohepatitis (MASH), a fatty liver disease affecting an estimated 1.5% to 6.5%...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of semaglutide's effectiveness in reducing liver inflammation and scarring in patients with MASH?

New research shows the Wegovy active ingredient, semaglutide, significantly reduced liver inflammation in about two-thirds and scarring in one-third of patients with MASH, a fatty liver disease affecting 1.5% to 6.5% of U.S. adults. Patients also lost an average of 8.5% of their body weight over 72 weeks. This is important because MASH can lead to liver failure, cancer, and death.

Showing 1 to 5 of 5 results